
Brian M Shuch MD
Minimally Invasive Surgery, Surgical Oncology
Associate Professor of Urology, Director of the UCLA Kidney Cancer Program
Join to view full profile
200 UCLA Medical PlzSte 140Los Angeles, CA 90095
Phone+1 310-206-8164
Fax+1 310-206-2369
Dr. Shuch is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Professor of Urology,
Director of the UCLA Kidney Cancer Program
Education & Training
National Institutes of Health Clinical CenterFellowship, Minimally Invasive Urologic Surgery, 2010 - 2013
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 2005 - 2010
UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Transitional Year, 2004 - 2005
New York University School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2006 - 2028
CT State Medical License 2013 - 2019
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Active Surveillance of the Small Renal Mass
- Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy Start of enrollment: 2017 Apr 28
- SPECT/CT for the Characterization of Renal Masses Start of enrollment: 2018 Dec 07
Publications & Presentations
PubMed
- Long-Term Survival after Percutaneous Image-Guided Thermal Ablation of Oligometastatic Renal Cell Carcinoma.Daniel H Kim, Pedram Keshavarz, Tristan D Tibbe, Robert D Suh, Fereidoun Abtin
Journal of Vascular and Interventional Radiology. 2026-11-01 - Long-Term Survival after Percutaneous Image-Guided Microwave Ablation of Pathologically Proven Renal Cell Carcinoma.Daniel H Kim, Lucia Chen, Brian Shuch, Allan Pantuck, David S K Lu
Journal of Vascular and Interventional Radiology. 2026-11-01 - 3 citationsPerformance of [Zr]girentuximab PET/CT in Predicting the Presence of Any Renal Malignancy: A Reanalysis of the ZIRCON Trial.Aboubacar Kaba, Pratik Kanabur, Jeremie Calais, Andrew M Scott, Jean-Christophe Bernhard
European Urology. 2026-10-01
Journal Articles
- Krebs-Cycle-Deficient Hereditary Cancer Syndromes Are Defined by Defects in Homologous-Recombination DNA RepairBrian Shuch, Ranjit S Bindra, Christopher D Corso, Peter M Glazer, Nature
Authored Content
- Decisional Regret and Financial Toxicity Among Patients with Benign Renal MassesOctober 2021
Press Mentions
TLX250-CDx (Zircaix) Included in Leading International Guidelines for Renal ImagingOctober 23rd, 2025
UCLA’s Multidisciplinary Program Transforms the Outlook for People with Von Hippel-Lindau DiseaseNovember 25th, 2024
Novel Imaging Technique Accurate for Detecting Clear-Cell Renal Cell CancerOctober 22nd, 2024
Grant Support
- NCI Research Specialist/Clinician Scientist Award for Urologic Oncology ResearchUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2028
Committees
- Member, NCI PDQ Kidney Cancer Board
- Kidney Cancer Committee, Society of Urologic Oncology Clinical Trials Consortium
- Co-PI of S1500 Trial, SWOG Genitourinary Cancer Group
Professional Memberships
- Member
- Member
- Society of Urologic Oncology (SUO)Member
External Links
- Faculty Pagehttps://www.uclahealth.org/brian-shuch
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: